Review decisions
Showing 1540 results of 2627 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00435
Product Type: Drug
Control Number: 213580
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2018-02-09
Decision / Authorization Date: 2018-09-21
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00436
Product Type: Drug
Control Number: 213581
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2018-02-09
Decision / Authorization Date: 2018-09-21
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00448
Product Type: Drug
Control Number: 214078
Manufacturer: AbbVie Corporation
Submission Type: Supplement to a New Drug Submission - Priority Review
Date Filed / Submission Date: 2018-02-28
Decision / Authorization Date: 2018-09-21
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00427
Product Type: Drug
Control Number: 212388
Manufacturer: Merck Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2018-01-02
Decision / Authorization Date: 2018-09-21
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00460
Product Type: Drug
Control Number: 215288
DIN(s): 02493012
Manufacturer: Cipher Pharmaceuticals Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2018-09-20
Issued / Original Publication Date: 2020-01-27
Decision / Authorization Date: 2019-10-10
Updated Date: 2024-06-18
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00477
Product Type: Drug
Control Number: 213920
DIN(s): 02480948
Manufacturer: Shire Pharma Canada ULC
Submission Type: New Drug Submission
Date Filed / Submission Date: 2018-02-22
Decision / Authorization Date: 2018-09-19
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00455
Product Type: Drug
Control Number: 219998
DIN(s): 02490315, 02490323, 02490331
Manufacturer: Bayer Inc.
Submission Type: New Drug Submission (New Active Substance) - Notice of Compliance with Conditions
Date Filed / Submission Date: 2018-09-18
Issued / Original Publication Date: 2019-12-18
Decision / Authorization Date: 2019-07-10
Updated Date: 2025-06-04
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00492
Product Type: Drug
Control Number: 206230
DIN(s): 02480824, 02480832, 02480840
Manufacturer: Ipsen Biopharmaceuticals Canada Inc.
Submission Type: New Drug Submission (New Active Substance) - Priority Review
Date Filed / Submission Date: 2017-06-06
Decision / Authorization Date: 2018-09-14
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00574
Product Type: Drug
Control Number: 211611
DIN(s): 02480808
Manufacturer: Bayer Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2017-11-27
Decision / Authorization Date: 2018-09-14
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00444
Product Type: Drug
Control Number: 210469
Manufacturer: Pfizer Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2017-10-20
Decision / Authorization Date: 2018-09-14